Shock.ppt
-
Upload
yaacub-ibrahim -
Category
Documents
-
view
26 -
download
1
description
Transcript of Shock.ppt
![Page 1: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/1.jpg)
SHOCK
![Page 2: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/2.jpg)
DEFINITION
• Profound hemodyamic and metabolic disturbance characterized by failure of the circulatory system to maintain adequate perfusion of vital organs
![Page 3: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/3.jpg)
Types of Shock
• Cardiogenic (intracardiac vs extracardiac)
• Hypovolemic
• Distributive– sepsis****– neurogenic (spinal shock)– adrenal insufficiency– anaphylaxis
![Page 4: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/4.jpg)
![Page 5: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/5.jpg)
Cardiogenic Shock, intracardiac
• Myocardial Injury or Obstruction to Flow– Arrythymias– valvular lesions– AMI– Severe CHF– VSD– Hypertrophic Cardiomyopathy
![Page 6: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/6.jpg)
Presentation of Cardiogenic Shock
• Pulmonary Edema
• JVD
• hypotensive
• weak pulses
• oliguria
![Page 7: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/7.jpg)
Cardiogenic Shock, extracardiac(Obstructive)
• Pulmonary Embolism
• Cardiac Tamponade
• Tension Pneumothorax
• Presentation will be according to underlying disease process.
![Page 8: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/8.jpg)
Hypovolemic Shock
• Reduced circulating blood volume with secondary decreased cardiac output– Acute hemorrhage– Vomiting/Diarrhea– Dehydration– Burns– Peritonitis/Pancreatitis
![Page 9: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/9.jpg)
Presentation of Hypovolemic Shock
• Hypotensive
• flat neck veins
• clear lungs
• cool, cyanotic extremities
• evidence of bleeding?– Anticoagulant use– trauma, bruising
• oliguria
![Page 10: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/10.jpg)
Distributive Shock
• Peripheral Vasodilation secondary to disruption of cellular metabolism by the effects of inflammatory mediators.
• Gram negative or other overwhelming infection.
• Results in decreased Peripheral Vascular Resistance.
![Page 11: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/11.jpg)
Distributive Shock: Presentation
• Febrile
• Tachycardic
• clear lungs, evidence of pneumonia
• warm extremities
• flat neck veins
• oliguria
![Page 12: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/12.jpg)
Diagnosing Shock
• Response to fluids
• Echo/EKG
• CXR
• Evidence of infection
• Swan-Ganz Catheter?
![Page 13: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/13.jpg)
Swan-Ganz Catheter
• Utilized to differentiate types of shock and assist in treatment response.
• Probably overused by physicians. Studies documenting increased mortality in patients with catheters versus no catheters, although somewhat swayed by selection bias.
![Page 14: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/14.jpg)
Swan-Ganz Catheter
![Page 15: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/15.jpg)
![Page 16: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/16.jpg)
Swan-Ganz Interpretation
Etiology CO PCWP SVR
cardiogenic decreased increased increased
hypovolemic decreased decreased increased
distributive increased decreased decreased
obstructive decreased Increased increased
![Page 17: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/17.jpg)
Management
• Correct underlying disorder if possible and then direct efforts at increasing the blood pressure to increase oxygen delivery to the tissues.
• Maintain a mean arterial pressure of 60 (1/3 systolic + 2/3 diastolic)
• Keep O2 sats >92%, intubate if neccesary
![Page 18: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/18.jpg)
Correction of hypotension
• Normal Saline should be administered anytime a patient is hypotensive. If hypotension exists give more NS. ***
• If possible give blood as it replaces colloid.
• Vasopressors
• Inotropic agents for cardiogenic shock
• Intra-aortic Balloon Pump for cardiogenic
![Page 19: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/19.jpg)
Autonomic Drugs in Shock
Drug Indication Dose MOA Principal actionsDopamine Renal perfusion 2-5 mcg/kg/min Dopaminergic Renal a. dilation
hypotension 5-10 mcg/kg/min 1 &dopaminergic
+ inotrope
Hypotension >10 mcg/kg/min 1 vasoconstrictionDobutamine Cardiogenic shock 2.5-25 mcg/kg/min Selective 1 + inotropeNorepinephrine Hypotension 2-4 mcg/min 1 & 1 VasoconstrictionPhenylephrine Hypotension 40-180 mcg/min Selective 1 Vasoconstriction
![Page 20: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/20.jpg)
Management of Cardiogenic Shock
• Attempt to correct problem and increase cardiac output by diuresing and providing inotropic support. IABP is utilized if medical therapy is ineffective. Catheterization if ongoing ischemia
• Cardiogenic shock is the exception to the rule that NS is always given for hypotension NS will exacerbate cardiac shock.
![Page 21: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/21.jpg)
Intra-Aortic Balloon Pump
![Page 22: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/22.jpg)
Management of Septic Shock
• Early goal directed therapy• Identification of source of infection• Broad Spectrum Antibiotics• IV fluids • Vasopressors• Steroids ??• Recombinant human activated protein C ( Xygris)• Bicarbonate if pH < 7.1
![Page 23: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/23.jpg)
Management of Hypovolemic Shock
• Correct bleeding abnormality
• If PT or PTT elevated then FFP
• Aggressive Fluid replacement with 2 large bore IV’s or central line.
• Pressors are last line, but commonly required.
![Page 24: Shock.ppt](https://reader030.fdocuments.in/reader030/viewer/2022032512/55cf9b58550346d033a5b126/html5/thumbnails/24.jpg)
Addison’s Disease
• Deficiency of cortisol and aldosterone production in the adrenal glands
• This is suspected when patient is non-responsive to fluids and antibiotics.
• Electrolytes may reveal hyponatremia and hyperkalemia
• Hydrocortisone 100 mg IV immediately then taper appropriately